VANCOUVER, British Columbia, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”), is pleased to announce the voting results from its annual general meeting of shareholders (the “Meeting”) held on December 16, 2025. All matters submitted to shareholders for approval at the Meeting were approved in accordance with management’s recommendations, including: (a) fixing the number of directors of the Company at six (6) and electing the following ind ...

公司近期业绩与预期更新 - 公司将于2026年1月13日举行分析师与投资者电话会议，届时管理层将提供2025年和2026年更新后的营收指引 [1] - 此次会议源于公司近期创纪录的交易更新，以及超出市场预期的年终业绩表现，该表现确认了创纪录的12月业绩、加速的营收势头以及正的调整后EBITDA [2] - 公司首席执行官Daniel Wagner和首席财务及运营官Arthur Yao将出席电话会议 [2] 2026年营收可见性与市场共识差异 - 公司已披露其2026年已签约的营收为2.09亿美元，这一数字显著超过当前分析师对该年约1.71亿美元的共识预期 [2] - 管理层认为市场仍然严重低估了其营收的规模和可见性，并计划在电话会议上直接解决这一差异，提供关于销售渠道转化、扩张活动和未来可见性的额外背景信息 [2][3] - 管理层计划基于已签约收入、已执行的部署和快速扩张的企业销售渠道，为2025年和2026年提供明确的指引，以重置市场预期 [3] 公司业务描述 - Rezolve Ai是AI驱动解决方案的行业领导者，专注于增强客户互动、运营效率和营收增长 [4] - 其Brain Suite是世界上首个为企业级智能商务构建的企业AI平台，提供先进的工具，利用人工智能在全球范围内驱动搜索、交易、履约和个性化服务 [4] 非GAAP财务指标定义 - 公司使用某些非GAAP财务指标，如年度经常性收入、EBITDA和调整后EBITDA，以补充其合并财务报表 [8] - 年度经常性收入定义为在适用期间最后一天来自客户的合同性月度经常性收入的年化价值 [9] - EBITDA定义为经利息支出、所得税、财产和设备折旧以及收购无形资产摊销调整后的净收入（亏损） [10] - 调整后EBITDA定义为EBITDA再经未实现外汇损益、与员工、顾问及相关方相关的股权激励、衍生资产和衍生负债在每个报告期末按公允价值重估产生的损益等多项调整后的结果 [10] 2025年ARR预测数据 - 公司预测2025年12月的月度经常性收入为1749万美元 [13] - 根据ARR定义，公司预测的2025年末ARR退出率为2.0988亿美元 [13]

Beijing, Dec. 19, 2025 (GLOBE NEWSWIRE) -- In a major advancement for AI model evaluation, the Institute of Artificial Intelligence of China Telecom (TeleAI) has introduced a groundbreaking metric—Information Capacity—that redefines how large language models (LLMs) are assessed beyond traditional size-based comparisons. This new approach reveals that true model “talent” lies not in size, but in how efficiently a model compresses and processes knowledge relative to its computational cost. Information capaci ...

BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced the pricing of an underwritten public offering of 35,714,286 shares of its common stock (or pre-funded warrants to purchase shares of common stock in lieu thereof) and accompanying common stock warrants to purchase an aggrega ...

NORCROSS, Ga., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced that the U.S. Food and Drug Administration (FDA) has provided a written response, and subsequent communications, to the Company’s previously submitted Type C meeting request regarding the development program for belapectin, its investigational galectin-3 inhibitor. The FDA converted the C ...

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- AGF Investments Inc. (AGF Investments) today announced the estimated December 2025 cash distributions for the AGF Investments ETFs listed on the Toronto Stock Exchange or Cboe Canada Inc. Unitholders of record of an AGF Investments ETF on December 31, 2025 will receive the actual cash distributions payable in respect of that AGF Investment ETF on January 7, 2026.AGF expects to issue a press release on or about December 30, 2025, which will provide the final cash di ...

MULTI-DAT Framework Drives Diversified Crypto Expansion and Volatility Hedging DALLAS, TX, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (the “Company”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced an up to $100 million Solana-focused digital asset treasury (DAT) strategy in partnership with Cube Group, through its newly formed subsidiary, M ...

Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna’s 2025 advances across R&D, clinical development, and medical affairs. TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products applauds President Trump’s executive order directing the reclassificati ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in Magnitude International Ltd (Nasdaq: MAGH) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MAGH from 04:00:00 on December 5, 2025 to 23:59:00 on December 18, 2025. The last sale price of the company’s shares was $6.76. More information about the SEC’s order can be found at https://www.sec.gov/files/ ...

(all figures in Canadian dollars) TORONTO and KNOXVILLE, Tenn., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR) is pleased to announce it has appointed a new Sales Director as the Company prepares for growth in 2026. Former Distributive Solar owner Erik Melang has joined Solar Alliance as Sales Director, bringing both the Distributive Solar and Nashville Solar Works brands under the Solar Alliance umbrella. This strategic addition to the Company ...